Journal
JOURNAL OF PHARMACEUTICAL ANALYSIS
Volume 12, Issue 2, Pages 221-231Publisher
ELSEVIER
DOI: 10.1016/j.jpha.2021.11.004
Keywords
Breast cancer; Diallyl disulfide; Diallyl trisulfide; Drug resistance; Metastasis
Categories
Funding
- UGC-DAE-CSR, Kolkata [KC/CRS/19/RB-04/1047]
Ask authors/readers for more resources
Breast cancer is a major cause of cancer-related deaths in women worldwide. The increase in tumor heterogeneity and aggressiveness has made the treatment of breast cancer challenging. High intake of certain Allium vegetables, such as garlic, has been associated with a reduced risk of developing breast cancer. DADS and DATS, compounds found in garlic, have anticancer activity and can interfere with breast cancer cell proliferation and metastasis. This review focuses on multidrug resistance mechanisms in breast cancer and discusses the potential anticancer activities of DADS and DATS, particularly in triple-negative breast cancer.
Breast cancer is one of the leading causes of cancer-related deaths in women worldwide. It is a cancer that originates from the mammary ducts and involves mutations in multiple genes. Recently, the treatment of breast cancer has become increasingly challenging owing to the increase in tumor heterogeneity and aggressiveness, which gives rise to therapeutic resistance. Epidemiological, population based, and hospital-based case-control studies have demonstrated an association between high intake of certain Allium vegetables and a reduced risk in the development of breast cancer. Diallyl disulfide (DADS) and diallyl trisulfide (DATS) are the main allyl sulfur compounds present in garlic, and are known to exhibit anticancer activity as they interfere with breast cancer cell proliferation, tumor metastasis, and angiogenesis. The present review highlights multidrug resistance mechanisms and their signaling pathways in breast cancer. This review discusses the potential anticancer activities of DADS and DATS, with emphasis on drug resistance in triple-negative breast cancer (TNBC). Understanding the anticancer activities of DADS and DATS provides insights into their potential in targeting drug resistance mechanisms of TNBC, especially in clinical studies.(c) 2021 The Authors. Published by Elsevier B.V. on behalf of Xi'an Jiaotong University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available